Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.52 [1.35-1.71],2.6697817138347e-12,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.84 [0.76-0.94],0.00130736228230585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.13 [1.05-1.23],0.00204785011859211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NFASC,Neurofascin,Inverse variance weighted,15,0.91 [0.85-0.97],0.00351790151985195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSD,Cathepsin D,Inverse variance weighted,17,1.11 [1.03-1.2],0.00478799636235964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.93 [0.88-0.98],0.00717969286129114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.16 [1.03-1.3],0.0136641959582462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.11 [1.01-1.21],0.0237648731156511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.94 [0.89-0.99],0.0246697066458372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.04 [1-1.08],0.0327827282587803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MFGE8,Lactadherin,Inverse variance weighted,11,1.08 [1.01-1.17],0.0363819582384318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.9 [0.82-0.99],0.0378662902846231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.08 [1-1.16],0.0395594778158186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.12 [1-1.24],0.0438967881657641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.93 [0.86-1],0.0477704351181104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VWC2,Brorin,Inverse variance weighted,22,1.08 [1-1.16],0.0479570451873447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.92 [0.84-1],0.058964512182614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.11 [1-1.24],0.060201496160419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MVK,Mevalonate kinase,Inverse variance weighted,2,0.77 [0.58-1.02],0.0646063188359938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSB,Cathepsin B,Inverse variance weighted,26,1.05 [1-1.11],0.065596816070348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.24 [0.98-1.56],0.0670147984224387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RTBDN,Retbindin,Inverse variance weighted,3,0.87 [0.75-1.01],0.0678165816112703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PALM2,Paralemmin-2,Inverse variance weighted,8,1.1 [0.99-1.22],0.0781867346202981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LDLR,Low-density lipoprotein receptor,Wald ratio,1,2.65 [0.88-7.97],0.0825499239097603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.86 [0.72-1.02],0.0853540538215364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.15 [0.98-1.35],0.0863210050915012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD302,CD302 antigen,Inverse variance weighted,9,0.93 [0.85-1.01],0.0878045681377048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.09 [0.99-1.2],0.0903625225034501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AREG,Amphiregulin,Inverse variance weighted,3,0.87 [0.73-1.03],0.0949652593884011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.89 [0.77-1.02],0.100340164318704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPON2,Spondin-2,Inverse variance weighted,4,0.91 [0.81-1.02],0.10336243412858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,0.92 [0.84-1.02],0.109620432237731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.96 [0.91-1.01],0.114853210699058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.16 [0.97-1.38],0.115084784236362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.08 [0.98-1.19],0.116197829205933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.73 [0.49-1.09],0.122903233123835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.93 [0.84-1.02],0.125190257571608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.08 [0.98-1.19],0.126589929088624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.26 [0.93-1.69],0.129560552635027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.87 [0.73-1.04],0.130781180671445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.95 [0.88-1.02],0.133471312602108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.03 [0.99-1.06],0.136016764601942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CNTN3,Contactin-3,Inverse variance weighted,14,0.95 [0.88-1.02],0.137892804800624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.1 [0.97-1.25],0.139477184607645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD276,CD276 antigen,Inverse variance weighted,20,0.97 [0.93-1.01],0.143478808856131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.14 [0.95-1.36],0.150601063276815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.87 [0.73-1.05],0.151573346910244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PGF,Placenta growth factor,Inverse variance weighted,2,1.62 [0.83-3.15],0.154257810967412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.91 [0.81-1.03],0.154658470670673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.94 [0.86-1.02],0.155675820215765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,1.04 [0.98-1.1],0.159555379180806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.07 [0.97-1.18],0.162617445298628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.26 [0.91-1.74],0.16808718558299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GRN,Progranulin,Inverse variance weighted,7,0.93 [0.84-1.03],0.17035695086532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.82 [0.62-1.09],0.171659050925163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.18 [0.93-1.49],0.174370298408699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.91 [0.79-1.04],0.179440636941082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS9,Galectin-9,Inverse variance weighted,26,0.96 [0.91-1.02],0.180362836458342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.08 [0.96-1.22],0.181018563326787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.8 [0.58-1.11],0.182093366611665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MENT,Protein MENT,Inverse variance weighted,3,1.04 [0.98-1.1],0.182203349696754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,1.18 [0.93-1.49],0.182261216698334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.64 [0.33-1.25],0.189731236250951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRSS8,Prostasin,Inverse variance weighted,5,1.13 [0.94-1.36],0.190347092825955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.06 [0.97-1.17],0.191162284994021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MUC13,Mucin-13,Inverse variance weighted,9,0.93 [0.84-1.04],0.200348988783108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.04 [0.98-1.1],0.203750255712368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCG2,Secretogranin-2,Wald ratio,1,1.43 [0.82-2.5],0.205515006423884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.05 [0.97-1.14],0.205839830648968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.11 [0.94-1.31],0.208401050643869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.12 [0.94-1.34],0.20871584690057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.67 [0.36-1.25],0.210462470581186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.06 [0.97-1.15],0.210888578094782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.22 [0.89-1.69],0.214639204578533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.33 [0.84-2.12],0.224277156649331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.05 [0.97-1.13],0.224672270731177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.04 [0.98-1.1],0.227855634252249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,F7,Coagulation factor VII,Inverse variance weighted,21,1.05 [0.97-1.13],0.228897888976675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.07 [0.96-1.2],0.234015696015969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.67 [0.35-1.3],0.235246826778833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.73 [0.43-1.23],0.241068628294194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.9 [0.76-1.07],0.243581932493301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.93 [0.83-1.05],0.244586835114565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.05 [0.96-1.15],0.250418071781126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.97 [0.93-1.02],0.251658257115129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1.02 [0.98-1.06],0.25290964140158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.95 [0.87-1.04],0.25724854514524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [0.98-1.09],0.259586142279647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.89 [0.72-1.1],0.264000643637825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.04 [0.97-1.11],0.272107527837497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.97 [0.93-1.02],0.272195816884029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.97 [0.91-1.03],0.272334524135604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.94 [0.85-1.05],0.274629409666678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.15 [0.9-1.47],0.275391307888031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.9 [0.74-1.09],0.277204833402577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.06 [0.95-1.18],0.283431605527399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.03 [0.98-1.08],0.290739264072826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EDN1,Endothelin-1,Inverse variance weighted,3,0.94 [0.83-1.06],0.293637801480958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.16 [0.88-1.54],0.297713354984831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.97 [0.92-1.02],0.307376663462931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.97 [0.9-1.03],0.30834925190087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PSAP,Prosaposin,Inverse variance weighted,5,1.09 [0.92-1.29],0.34214878493713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.13 [0.88-1.46],0.349271791462698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.95 [0.86-1.06],0.365518263575502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.07 [0.93-1.23],0.365928934865298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.92 [0.77-1.1],0.373778950839964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRSS2,Trypsin-2,Inverse variance weighted,3,0.91 [0.73-1.13],0.377503826202644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.02 [0.98-1.05],0.387884113179544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.03 [0.96-1.1],0.390504139110533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.05 [0.94-1.18],0.390757221482795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.94 [0.82-1.08],0.398808340612571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.94-1.02],0.404389371795875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.05 [0.93-1.19],0.406429400166508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.9 [0.69-1.16],0.410662118078009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.88 [0.64-1.2],0.424303652167312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,0.96 [0.85-1.07],0.433993229810826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.98-1.05],0.439006233416519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PGA4,Pepsin A-4,Inverse variance weighted,2,1.15 [0.81-1.63],0.445176455096002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PENK,Proenkephalin-A,Inverse variance weighted,19,1.03 [0.96-1.1],0.450596527747497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COLEC12,Collectin-12,Inverse variance weighted,11,0.95 [0.84-1.08],0.45695707013769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.14 [0.8-1.63],0.463643045303409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CFI,Complement factor I,Inverse variance weighted,6,1.04 [0.93-1.17],0.466028342687231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AGRN,Agrin,Inverse variance weighted,17,0.97 [0.9-1.05],0.472011946200872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.03 [0.95-1.11],0.475346853241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MDK,Midkine,Inverse variance weighted,4,1.09 [0.86-1.39],0.476718181367774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OCLN,Occludin,Inverse variance weighted,2,0.93 [0.76-1.14],0.487591734646161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.02 [0.96-1.08],0.488885978454414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.08 [0.86-1.36],0.492380125870889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.95 [0.81-1.11],0.493004991474978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,0.98 [0.93-1.04],0.493679750632498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,UMOD,Uromodulin,Inverse variance weighted,29,1.01 [0.97-1.06],0.500533162538502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.97-1.06],0.501061651562178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.04 [0.94-1.15],0.50485772953055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REN,Renin,Inverse variance weighted,4,1.03 [0.94-1.14],0.509260091903282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AMBP,Protein AMBP,Inverse variance weighted,3,1.12 [0.79-1.6],0.518607806411894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.97 [0.89-1.06],0.521617541079025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NECTIN2,Nectin-2,Inverse variance weighted,5,0.92 [0.7-1.2],0.522887624672231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.85 [0.51-1.41],0.524952395539098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.88 [0.6-1.3],0.525343719734256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.97 [0.88-1.07],0.529970016035613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.94 [0.78-1.14],0.533429550041656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.95 [0.82-1.1],0.534369061875494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.02 [0.95-1.1],0.553352091610839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.93-1.04],0.554300062803828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.1 [0.8-1.5],0.557277748847317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.93 [0.72-1.19],0.560008198870217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.98 [0.91-1.06],0.563668420783452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.03 [0.92-1.16],0.566197113377344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.05 [0.89-1.23],0.570324342853835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.02 [0.95-1.11],0.571599849244781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.02 [0.95-1.09],0.574324832252468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.03 [0.93-1.13],0.576495269748937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.03 [0.93-1.13],0.578795215124819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CFD,Complement factor D,Inverse variance weighted,11,0.97 [0.86-1.09],0.580017534664061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FURIN,Furin,Wald ratio,1,1.04 [0.9-1.21],0.586783850581714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.98 [0.89-1.07],0.586806881657796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.04 [0.91-1.18],0.587951892020018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.97 [0.87-1.08],0.588498985992882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.02 [0.95-1.09],0.590789557209959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.87 [0.54-1.43],0.591853657277561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.2 [0.61-2.39],0.596121055371488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.98 [0.91-1.06],0.596579600251335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS3,Galectin-3,Inverse variance weighted,25,1.02 [0.96-1.08],0.599700108778769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.96 [0.82-1.12],0.607669441898259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.01 [0.98-1.04],0.614779952347053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.07 [0.82-1.4],0.618169146568552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.05 [0.86-1.28],0.619318811410102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.96 [0.8-1.15],0.627066805763055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BCHE,Cholinesterase,Inverse variance weighted,30,0.99 [0.93-1.05],0.632103487113595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.85 [0.44-1.64],0.638469305487992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.98 [0.91-1.06],0.643459288758579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.99 [0.94-1.04],0.643885191456513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.11 [0.71-1.74],0.648337751271749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.96 [0.81-1.14],0.657242409217941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.99 [0.95-1.04],0.660556854682792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ELN,Elastin,Inverse variance weighted,2,1.08 [0.77-1.52],0.660665615902364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.99 [0.93-1.05],0.674078718226561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.87 [0.46-1.65],0.676835519813826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.01 [0.97-1.05],0.67973339169095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MMP7,Matrilysin,Inverse variance weighted,13,1.02 [0.94-1.1],0.680790580499393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCN1,CCN family member 1,Inverse variance weighted,2,1.04 [0.83-1.32],0.71873729233438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.95 [0.69-1.29],0.720776413539208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.11 [0.63-1.95],0.722549397514724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.98 [0.89-1.08],0.723138148682624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.97 [0.8-1.17],0.734489049439167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.99 [0.95-1.04],0.735086354910785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.92-1.13],0.738042406365166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.93 [0.61-1.42],0.739754827673258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.01 [0.94-1.09],0.750031795667726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.99 [0.92-1.06],0.750126914936385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.02 [0.89-1.17],0.755988937750984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.95 [0.68-1.32],0.759286722050424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.95-1.04],0.759644716746254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FUOM,Fucose mutarotase,Inverse variance weighted,3,1.04 [0.82-1.31],0.766006274708172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.99 [0.89-1.09],0.774873823395214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.98 [0.86-1.12],0.775433654754011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANXA10,Annexin A10,Wald ratio,1,0.93 [0.55-1.56],0.779273193985051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTN,Pleiotrophin,Inverse variance weighted,4,0.97 [0.78-1.21],0.783519184771141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.01 [0.95-1.08],0.783936384372589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.01 [0.95-1.07],0.791700228434991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.03 [0.81-1.31],0.798262027781932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.99 [0.92-1.07],0.803403747843926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CST3,Cystatin-C,Inverse variance weighted,10,1.01 [0.93-1.09],0.812067904298361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,0.96 [0.67-1.37],0.814032764112889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHGA,Chromogranin-A,Inverse variance weighted,3,1.02 [0.89-1.16],0.818008347043402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.99 [0.88-1.1],0.82578513522915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.95-1.04],0.828330608143536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.01 [0.91-1.12],0.830068510302088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.97-1.04],0.830526158913141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.04 [0.74-1.45],0.837371268438224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1 [0.97-1.04],0.84016741858629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.01 [0.9-1.14],0.840853998936717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.01 [0.9-1.14],0.847536944681311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.93-1.06],0.848244791819655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.02 [0.81-1.29],0.850042789032553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.95-1.04],0.852416221001474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.97 [0.71-1.33],0.863043785318401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LMNB2,Lamin-B2,Wald ratio,1,1.06 [0.55-2.02],0.863899902564308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.99 [0.88-1.11],0.868638041976453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,0.97 [0.64-1.45],0.870387693366191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSO,Cathepsin O,Inverse variance weighted,6,1.01 [0.9-1.14],0.877726484766542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLG,Plasminogen,Inverse variance weighted,20,0.99 [0.89-1.11],0.879599317777321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MME,Neprilysin,Inverse variance weighted,3,0.97 [0.62-1.52],0.890727804273472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.97-1.03],0.894945160703065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.01 [0.92-1.1],0.89957497004478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.99 [0.87-1.12],0.901088151722629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SOST,Sclerostin,Wald ratio,1,1.03 [0.63-1.67],0.90348672339923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AGRP,Agouti-related protein,Inverse variance weighted,3,1.02 [0.7-1.49],0.910187046559021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.99 [0.82-1.2],0.9116306525169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1 [0.95-1.05],0.914818937442282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS4,Galectin-4,Inverse variance weighted,4,0.99 [0.81-1.21],0.920344111882959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.94-1.06],0.921472924066842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCN3,CCN family member 3,Inverse variance weighted,19,1 [0.93-1.09],0.923316950406159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1 [0.91-1.11],0.928779693492525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.99 [0.79-1.23],0.930684606216369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,1 [0.94-1.07],0.932508379457662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.99 [0.78-1.25],0.934258631783551,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CSTB,Cystatin-B,Inverse variance weighted,28,1 [0.95-1.06],0.940272287758335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.94-1.07],0.945313625430871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.89-1.13],0.95045905105241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1 [0.86-1.17],0.953934868608666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAYN,Layilin,Inverse variance weighted,20,1 [0.93-1.08],0.957921473889029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.01 [0.83-1.22],0.95823430150393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.99 [0.62-1.58],0.960612225747386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1 [0.93-1.07],0.969251829704158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,1 [0.84-1.2],0.96987806981153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1 [0.85-1.17],0.970441976669522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,22,1 [0.95-1.05],0.971292894749278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1 [0.86-1.17],0.979502316498097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD83,CD83 antigen,Inverse variance weighted,5,1 [0.87-1.14],0.982680259416692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1 [0.8-1.25],0.988926598252927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPO,Erythropoietin,Inverse variance weighted,5,1 [0.72-1.4],0.989341356452746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANG,Angiogenin,Inverse variance weighted,19,1 [0.93-1.08],0.990276698718359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1 [0.82-1.22],0.992296979115753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1 [0.87-1.15],0.997641908194458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CDH2,Cadherin-2,Inverse variance weighted,3,1 [0.67-1.49],0.998121388519421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1 [0.96-1.04],0.999375618968964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,3.81 [1.98-7.33],6.36367261160714e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.91 [1.36-2.68],0.000199219791343881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GRN,Progranulin,Inverse variance weighted,46,1.12 [1.05-1.2],0.000470490118229562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.85 [0.78-0.94],0.000944775040644713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.28 [1.09-1.51],0.00299666206440538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS4,Galectin-4,Inverse variance weighted,15,0.89 [0.82-0.97],0.00663696528380106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.66 [0.48-0.89],0.0075678155063414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.16 [1.04-1.29],0.00908604118782633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.84 [0.73-0.96],0.00985741215611478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCN1,CCN family member 1,Inverse variance weighted,6,1.66 [1.13-2.45],0.00999304169606797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.47 [0.26-0.83],0.0101223851772602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.26 [1.05-1.5],0.0106161056100515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.5 [0.29-0.86],0.0124623206169817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.15 [1.03-1.29],0.0141458461136215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,2.88 [1.18-7.04],0.0205691384922283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.11 [1.02-1.21],0.021162837047222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.23 [1.03-1.46],0.0236892436109087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.15 [1.02-1.29],0.0249725665495035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.86 [0.76-0.98],0.0272512366497403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.79 [0.65-0.97],0.027515859742146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,6,1.5 [1.04-2.15],0.028409792837804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.08 [1.01-1.16],0.0284218443270746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.85 [0.73-0.99],0.0326399659973265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.86 [0.75-0.99],0.0338617130541571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.54 [1-2.36],0.0507131133002993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.7 [0.99-2.9],0.0539857861740423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.2 [1-1.45],0.0555720703452658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.1 [1-1.22],0.0572158527328508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLG,Plasminogen,Inverse variance weighted,6,1.23 [0.99-1.51],0.0578129806317301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.95 [0.9-1],0.0586364339658472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.95 [0.89-1],0.0591732272617253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPON1,Spondin-1,Inverse variance weighted,4,1.32 [0.99-1.76],0.0606582137679553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CST3,Cystatin-C,Inverse variance weighted,3,1.39 [0.98-1.99],0.0675148463090995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PALM2,Paralemmin-2,Inverse variance weighted,9,1.1 [0.99-1.22],0.072019053195145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AGRN,Agrin,Inverse variance weighted,14,1.14 [0.99-1.31],0.0747057946417752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GCG,Pro-glucagon,Inverse variance weighted,2,0.69 [0.46-1.04],0.0779797808396989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.16 [0.98-1.37],0.0783002103690998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAYN,Layilin,Inverse variance weighted,3,1.38 [0.96-1.99],0.0796388887840603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.19 [0.98-1.46],0.0835970255554596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MENT,Protein MENT,Inverse variance weighted,28,1.11 [0.99-1.25],0.0857896188176397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.17 [0.98-1.4],0.0863882074792614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.2 [0.97-1.48],0.0900935111504558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.03 [1-1.07],0.0903044444488495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.2 [0.97-1.47],0.092207889523525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.79 [0.6-1.05],0.100658065538634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.86 [0.71-1.03],0.104073476174448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MUC13,Mucin-13,Inverse variance weighted,3,0.71 [0.47-1.07],0.104960500836662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.9 [0.8-1.02],0.10899858839674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.94 [0.86-1.02],0.112313127586074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VWC2,Brorin,Inverse variance weighted,12,1.15 [0.97-1.36],0.115528936877786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.17 [0.96-1.43],0.120959313801131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.18 [0.95-1.46],0.128193645940463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.96 [0.91-1.01],0.132271368931167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,0.96 [0.91-1.01],0.136427794306164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PGA4,Pepsin A-4,Inverse variance weighted,7,0.84 [0.67-1.06],0.138502307304226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.29 [0.92-1.81],0.139970587424731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.74 [0.49-1.11],0.140993045424219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.09 [0.97-1.21],0.143711741175894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.4 [0.88-2.22],0.151513510399406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.71 [0.44-1.14],0.155234928343181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.32 [0.9-1.93],0.156060308684477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NFASC,Neurofascin,Inverse variance weighted,6,0.73 [0.47-1.13],0.157609504312951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.13 [0.95-1.33],0.158512680765715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.39 [0.88-2.19],0.160005244703734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.31 [0.9-1.93],0.160840335138456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.43 [0.87-2.35],0.160922344702598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.75 [0.5-1.12],0.161732239371742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MFGE8,Lactadherin,Inverse variance weighted,15,1.21 [0.93-1.57],0.163187534209642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AGRP,Agouti-related protein,Inverse variance weighted,16,1.17 [0.94-1.46],0.166473246887395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.2 [0.92-1.57],0.176524632189694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.81 [0.59-1.1],0.17673290213219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.86 [0.69-1.07],0.176829560722032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OMD,Osteomodulin,Inverse variance weighted,15,1.08 [0.96-1.22],0.177109449486367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.97 [0.93-1.01],0.177431895925553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.17 [0.93-1.48],0.180412007096197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.09 [0.96-1.24],0.183958733347346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD276,CD276 antigen,Inverse variance weighted,24,0.94 [0.86-1.03],0.185937016835776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.41 [0.84-2.35],0.190102004148755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.34 [0.86-2.08],0.193738203836356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BCHE,Cholinesterase,Inverse variance weighted,38,1.04 [0.98-1.11],0.197233697561823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.35 [0.86-2.12],0.197670468422219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.16 [0.92-1.45],0.206211115014995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.9 [0.77-1.06],0.213835949463488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.85 [0.65-1.11],0.22167355050461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSO,Cathepsin O,Inverse variance weighted,19,0.86 [0.68-1.1],0.229176433072452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.35 [0.83-2.19],0.233639016455854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.78 [0.52-1.17],0.234702814696504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.22 [0.88-1.69],0.235876392420258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.17 [0.9-1.52],0.240461781761014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.27 [0.84-1.94],0.256693727852718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS9,Galectin-9,Inverse variance weighted,36,0.97 [0.92-1.02],0.258638103399334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.3 [0.82-2.05],0.267728967290387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GAST,Gastrin,Inverse variance weighted,9,0.92 [0.8-1.07],0.284797012542098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.92 [0.79-1.08],0.292987615901783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.17 [0.87-1.58],0.301074621702486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AMBP,Protein AMBP,Inverse variance weighted,5,1.16 [0.87-1.55],0.30221231498809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.33 [0.77-2.31],0.311940312596655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.89 [0.71-1.12],0.31508590953353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.9 [0.74-1.1],0.31899690441585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.75 [0.42-1.34],0.333077435917021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.9 [0.73-1.11],0.333408336347346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MVK,Mevalonate kinase,Wald ratio,1,1.93 [0.5-7.42],0.336299999895854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.28 [0.77-2.1],0.340364384238714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.28 [0.77-2.14],0.342331870222198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.18 [0.83-1.69],0.354728885808152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.97-1.07],0.356759348540577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.94-1.18],0.357292972582751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.17 [0.84-1.63],0.358747490615153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.07 [0.93-1.24],0.359381517198842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSD,Cathepsin D,Inverse variance weighted,7,1.1 [0.9-1.35],0.360435150299233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.09 [0.91-1.29],0.361300281223329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.17 [0.83-1.65],0.369918415797009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.04 [0.96-1.12],0.374499923621344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.94 [0.83-1.07],0.37600287991451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.95 [0.85-1.07],0.388944087470874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.12 [0.86-1.46],0.396790065201165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FURIN,Furin,Inverse variance weighted,3,0.87 [0.64-1.2],0.402673120894498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.12 [0.85-1.47],0.405093641756441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.92 [0.76-1.12],0.407223131946541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.04 [0.94-1.16],0.415304788921279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.96 [0.87-1.06],0.417554130926701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.89 [0.67-1.18],0.418824946957553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.93-1.03],0.4194907951095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.23 [0.74-2.04],0.432197203253008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.13 [0.83-1.55],0.440539382777721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MMP7,Matrilysin,Wald ratio,1,0.91 [0.72-1.16],0.451886533924221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.91 [0.71-1.17],0.461012640955687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.02 [0.96-1.08],0.477737005893306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CNTN3,Contactin-3,Inverse variance weighted,20,0.94 [0.79-1.12],0.488654327498001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSS,Cathepsin S,Inverse variance weighted,7,0.93 [0.75-1.15],0.499635620170483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.06 [0.9-1.25],0.504999798350584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.02 [0.97-1.07],0.50811622492587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.91 [0.69-1.2],0.508793863177356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CTSB,Cathepsin B,Inverse variance weighted,28,0.97 [0.88-1.07],0.510293986182883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.85 [0.52-1.38],0.513643804281873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.93 [0.75-1.16],0.523857453591238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCN3,CCN family member 3,Inverse variance weighted,17,1.03 [0.95-1.11],0.529166611084988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.84-1.1],0.529334958306273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.94 [0.78-1.14],0.533429550041656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.06 [0.88-1.28],0.533659508615404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTN,Pleiotrophin,Inverse variance weighted,3,1.09 [0.82-1.46],0.535141596063794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.97 [0.88-1.07],0.539940521549918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1.01 [0.97-1.05],0.542929811800675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.07 [0.85-1.36],0.543375821620759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.27 [0.58-2.79],0.547197712680758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,0.93 [0.74-1.18],0.551389630937088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,UMOD,Uromodulin,Inverse variance weighted,34,0.97 [0.87-1.07],0.553028108373017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.94 [0.76-1.16],0.556666051260332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.93 [0.72-1.2],0.559495672693434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.94 [0.75-1.17],0.560144262224265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.94 [0.76-1.16],0.5639569171762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.87 [0.54-1.4],0.566234279028182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.12 [0.76-1.64],0.56857777318831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ELN,Elastin,Inverse variance weighted,10,1.13 [0.74-1.72],0.568819592824293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.11 [0.78-1.57],0.57183677771279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.95 [0.8-1.13],0.573685007394585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.95 [0.81-1.12],0.575308208603205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.08 [0.82-1.42],0.579840106729062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.08 [0.82-1.43],0.582471129417445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PSAP,Prosaposin,Inverse variance weighted,13,1.03 [0.92-1.17],0.5864546764053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.02 [0.94-1.11],0.595579463966087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.97 [0.86-1.09],0.596414986024961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.93 [0.7-1.23],0.603173112901608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.05 [0.87-1.27],0.603663583930602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.11 [0.75-1.63],0.604556309625917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.15 [0.67-1.99],0.613465780551405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,0.96 [0.82-1.13],0.619674361934685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GUCA2A,Guanylin,Inverse variance weighted,7,0.96 [0.8-1.14],0.623395626204452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CFI,Complement factor I,Wald ratio,1,0.82 [0.37-1.83],0.631831133540496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.92 [0.64-1.31],0.638959176090197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.08 [0.79-1.47],0.640415608724735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.07 [0.81-1.4],0.64204547558904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,0.94 [0.74-1.2],0.642399297385597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.07 [0.79-1.45],0.645148741790376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.05 [0.83-1.33],0.670216562624841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MME,Neprilysin,Inverse variance weighted,46,1.01 [0.95-1.07],0.68205280629271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.91 [0.59-1.41],0.683699656608023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ANG,Angiogenin,Inverse variance weighted,8,1.07 [0.78-1.46],0.693734450019591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.05 [0.83-1.32],0.695220185931429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.01 [0.96-1.06],0.697432966466908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.86 [0.4-1.86],0.697622856419975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,POF1B,Protein POF1B,Inverse variance weighted,4,1.05 [0.83-1.32],0.698115622586092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.92 [0.6-1.41],0.700059123920605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.73 [0.14-3.76],0.704099498334394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.96 [0.77-1.19],0.705219965045898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.96 [0.78-1.19],0.708600031068433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,XG,Glycoprotein Xg,Inverse variance weighted,2,0.91 [0.56-1.48],0.710217290708565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LEP,Leptin,Inverse variance weighted,4,1.16 [0.52-2.59],0.712939403627166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SOST,Sclerostin,Inverse variance weighted,31,1.02 [0.93-1.11],0.718865317520914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.97 [0.82-1.15],0.722775270601879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NECTIN2,Nectin-2,Inverse variance weighted,3,1.11 [0.61-2.02],0.723549837686339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CHGA,Chromogranin-A,Inverse variance weighted,5,0.97 [0.8-1.17],0.726048889221672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.06 [0.76-1.48],0.729354440419724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.96 [0.77-1.2],0.730414599197678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.98 [0.85-1.12],0.730970464791953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LMNB2,Lamin-B2,Inverse variance weighted,8,1.03 [0.85-1.26],0.732829504608696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.03 [0.85-1.25],0.738591048897019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.98 [0.87-1.11],0.740338025022881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.98 [0.87-1.1],0.741801103721589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.97 [0.8-1.17],0.743760816558207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRSS2,Trypsin-2,Inverse variance weighted,17,0.98 [0.84-1.14],0.749462756745265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.02 [0.89-1.17],0.755988937750984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.01 [0.93-1.11],0.757021411278761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPON2,Spondin-2,Inverse variance weighted,3,0.95 [0.66-1.35],0.763725206190827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MDK,Midkine,Inverse variance weighted,14,0.97 [0.81-1.17],0.766497056855309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.99 [0.9-1.08],0.766804646023637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.05 [0.76-1.45],0.7689877262865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,C7,Complement component C7,Inverse variance weighted,26,1.01 [0.96-1.06],0.772768186741783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.05 [0.77-1.43],0.773239605326907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.97 [0.82-1.16],0.775364351491956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RTBDN,Retbindin,Inverse variance weighted,2,1.14 [0.45-2.92],0.781273976948153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.99 [0.93-1.06],0.785920654932276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.04 [0.77-1.42],0.791179421859469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.98 [0.83-1.15],0.791253593454584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD302,CD302 antigen,Inverse variance weighted,11,0.98 [0.85-1.13],0.791415110144099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PGF,Placenta growth factor,Inverse variance weighted,5,1.04 [0.76-1.43],0.794543514897447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PENK,Proenkephalin-A,Inverse variance weighted,15,1.01 [0.91-1.13],0.805231919592611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,1.01 [0.95-1.07],0.8127655130319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.94-1.05],0.813399592852074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CFD,Complement factor D,Wald ratio,1,0.94 [0.54-1.63],0.817321219221612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.08 [0.55-2.11],0.822917177560408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD83,CD83 antigen,Inverse variance weighted,14,0.98 [0.81-1.19],0.824612246860219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.02 [0.83-1.25],0.83956578260187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,REN,Renin,Inverse variance weighted,8,0.98 [0.81-1.19],0.840302810794554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.98 [0.84-1.15],0.846186474521547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.02 [0.8-1.32],0.849087906446545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.94 [0.49-1.81],0.85036282835956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.97 [0.73-1.29],0.851282109722895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.92 [0.4-2.15],0.852620520162394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.01 [0.88-1.16],0.867475740163503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.02 [0.83-1.25],0.868075979371059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SCG2,Secretogranin-2,Inverse variance weighted,2,0.91 [0.28-2.97],0.877497912572844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.02 [0.8-1.3],0.884233934749827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.99 [0.93-1.07],0.887225193050128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPO,Erythropoietin,Inverse variance weighted,11,1.01 [0.88-1.16],0.887868449044911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PRSS8,Prostasin,Inverse variance weighted,14,0.99 [0.87-1.12],0.88819135092908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.91 [0.24-3.44],0.891187100883794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,F7,Coagulation factor VII,Inverse variance weighted,10,0.99 [0.84-1.16],0.900944353269778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.99 [0.84-1.17],0.911881052636474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.99 [0.86-1.14],0.912269687760441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CDH2,Cadherin-2,Inverse variance weighted,21,0.99 [0.78-1.24],0.914767566896386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.98 [0.74-1.32],0.918357290234294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LGALS3,Galectin-3,Inverse variance weighted,15,1.01 [0.88-1.15],0.918974458352676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,COLEC12,Collectin-12,Inverse variance weighted,3,1.02 [0.61-1.73],0.927455824104904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.01 [0.73-1.41],0.928925071060694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.01 [0.75-1.37],0.929939589543609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.97-1.04],0.938544184935818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,1.01 [0.82-1.24],0.94007954875133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.94-1.06],0.942507324147741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.98 [0.6-1.61],0.944552590849428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.99 [0.67-1.46],0.945009921471596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1 [0.91-1.1],0.945426063789442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,F9,Coagulation factor IX,Inverse variance weighted,3,0.99 [0.72-1.37],0.946687700170175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.99 [0.81-1.21],0.948048763208276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,AREG,Amphiregulin,Inverse variance weighted,5,0.99 [0.76-1.29],0.948241030795301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.02 [0.51-2.04],0.952162969569829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,1 [0.9-1.12],0.955313392027432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.01 [0.67-1.54],0.959341355831794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,UPB1,Beta-ureidopropionase,Wald ratio,1,1.03 [0.23-4.69],0.969638685842921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,1 [0.84-1.2],0.96987806981153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1 [0.81-1.23],0.969922029735359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.01 [0.63-1.61],0.972633664993042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1 [0.74-1.36],0.97983397118419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.01 [0.57-1.79],0.983814000506909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1 [0.94-1.07],0.987331800474693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,OCLN,Occludin,Inverse variance weighted,2,1 [0.69-1.44],0.992451343889522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1 [0.72-1.38],0.998358509489079,trans
